SmartAnalyst provides comprehensive, integrated solutions based on our deep understanding of the science, the market, and the key business decisions that our clients face. We deploy agile, cross-functional project teams that are responsive to client needs. Our experienced team of experts use our proprietary strategic frameworks to help biopharma companies make key decisions at the Disease, Asset, and Portfolio levels, including:

 

Integrated Disease and Franchise Strategy

  • Where to play?
  • How to prioritize strategic choices?
  • How to win over the 3-5-7-10 year time horizon?
  • How to maximize value?
  • How to balance internal development vs. external BD&L opportunities?

Asset Strategy

  • Where to play?
  • How to prioritize strategic choices?
  • How to win over the 3-5-7-10 year time horizon?
  • How to maximize value?
  • How to balance internal development vs. external BD&L opportunities?

Portfolio Strategy

  • What are the portfolio goals (financial, non-financial) and risk tolerance?
  • What is the holistic portfolio beyond the sum of individual assets?
  • What are the intra-portfolio synergies/correlations?
  • What is the optimal portfolio composition and sequence?

Services: